Lindsay A McNair, MD, MPH
Adjunct Assistant Professor
Boston University School of Public Health
Dept of Epidemiology

MD, University of Connecticut
MPH, Boston University



Lindsay McNair, MD, MPH, MSBioethics is the Chief Medical Officer for the WIRB-Copernicus Group (WCG). Dr. McNair has extensive experience in the pharmaceutical industry working in clinical research and drug development. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and study designs for new drug studies, and medical oversight of all phases of clinical trials. Dr. McNair is adjunct faculty at Boston University and teaches graduate-level courses on the scientific design of clinical research studies, research ethics and the responsible conduct of research, and the development of clinical study protocols. She now oversees the physician team within the WCG IRBs, and provides consultation to institutions and pharma/biotech companies on a wide range of issues related to protocol design, regulatory compliance, human subject protection, and ethical policy development (compassionate use, etc).

Dr. McNair graduated from the University of Connecticut School of Medicine and trained in general surgery at Boston University Medical Center. She completed her Master’s in Public Health at Boston University concentrating in Biostatistics/Epidemiology, and her Master’s of Science in Bioethics at Union Graduate College concentrating in research ethics. She was a member of the Institutional Review Board at Boston University Medical Center, and founded and chaired the Human Subject Protection Committee at Vertex Pharmaceuticals. She was a site visitor for the Association of the Accreditation of Human Research Protection Programs (AAHRPP). Dr. McNair serves on committees including the Multi-Regional Clinical Trials Center at Harvard, and is an associate editor of the Journal of Empirical Research on Human Research Ethics.


Lymphedema in Survivors of Early Breast Cancer
10/01/1999 - 03/31/2004 (PI)
Susan G. Komen Breast Cancer Foundation


Lymphedema In Survivors Of Ear
01/01/1999 - 09/30/2002 (PI)
DPH

Lymphedema In Survivors Of Ebc
10/01/1999 - 01/16/2000 (PI)
Susan G. Komen for the Cure



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Li RH, Wacholtz MC, Barnes M, Boggs L, Callery-D'Amico S, Davis A, Digilova A, Forster D, Heffernan K, Luthin M, Lynch HF, McNair L, Miller JE, Murphy J, Van Campen L, Wilenzick M, Wolf D, Woolston C, Aldinger C, Bierer BE. Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees. J Med Ethics. 2016 Apr; 42(4):229-34. PMID: 26811365; PMCID: PMC4819642; DOI: 10.1136/medethics-2014-102540;.
  2. Cooper JA, McNair L. Sham Surgery Research. J Empir Res Hum Res Ethics. 2015 Dec; 10(5):496-8. PMID: 26564946; DOI: 10.1177/1556264615614942;.
  3. McNair LA, Biffl WL. Assessing Awareness and Implementation of a Recommendation for Surgical Innovation Committees: A Survey of Academic Institutions. Ann Surg. 2015 Dec; 262(6):941-8. PMID: 25373465; DOI: 10.1097/SLA.0000000000001037;.
  4. Cooper JA, McNair L. How to distinguish research from quality improvement. J Empir Res Hum Res Ethics. 2015 Apr; 10(2):209-10. PMID: 25819760; DOI: 10.1177/1556264615575513;.
  5. Cooper JA, McNair L. Simplifying the complexity of confidentiality in research. J Empir Res Hum Res Ethics. 2015 Feb; 10(1):100-2. PMID: 25742671; DOI: 10.1177/1556264614568783;.
  6. Cooper JA, McNair L. What Is the Role of a Statistician on the IRB? J Empir Res Hum Res Ethics. 2014 Dec; 9(5):89-90. PMID: 25747693; DOI: 10.1177/1556264614554899;.
  7. Cooper JA, McNair L. IRB Authority. J Empir Res Hum Res Ethics. 2014 Oct; 9(4):86-7. PMID: 25747299; DOI: 10.1177/1556264614548836;.
  8. Curry MP, Forns X, Chung RT, Terrault NA, Brown R, Fenkel JM, Gordon F, O''Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1.View Related Profiles. PMID: 25261839; DOI: 10.1053/j.gastro.2014.09.023;.
  9. Cooper JA, McNair L. Scientific review by the ethics committee. J Empir Res Hum Res Ethics. 2014 Jul; 9(3):93-4. PMID: 25746791; DOI: 10.1177/1556264614540590;.
  10. Garg V, Chandorkar G, Yang Y, Adda N, McNair L, Alves K, Smith F, van Heeswijk RP. The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers. Br J Clin Pharmacol. 2013 Feb; 75(2):431-9. PMID: 22642697; PMCID: PMC3579258; DOI: 10.1111/j.1365-2125.2012.04345.x;.
Showing 10 of 24 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 24 publications over 12 distinct years, with a maximum of 4 publications in 2014 and 2015

YearPublications
19921
20021
20051
20061
20072
20083
20093
20122
20131
20144
20154
20161
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


McNair's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department